Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 13,946.00p on 04-11-2026 at 13:15:27
Change 186.00p 1.35%
Buy 13,948.00p
Sell 13,944.00p
Last Trade: Buy 8.00 at 13,946.00p
Day's Volume: 629,298
Last Close: 13,760.00p
Open: 13,768.00p
ISIN: GB0009895292
Day's Range 13,582.00p - 13,954.00p
52wk Range: 11,404.00p - 15,730.00p
Market Capitalisation: £216.29b
VWAP: 13,701.51392p
Shares in Issue: 1.55b

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 8 13,946.00p Automatic Execution
13:15:22 - 04-Nov-26
Buy* 87 13,946.00p Automatic Execution
13:15:22 - 04-Nov-26
Sell* 13 13,944.00p Automatic Execution
13:15:20 - 04-Nov-26
Sell* 3 13,944.00p Automatic Execution
13:15:20 - 04-Nov-26
Unknown* 0 13,962.99824p Currency Conversion
OTC Trade
13:15:16 - 04-Nov-26
Sell* 49 13,942.00p Automatic Execution
13:15:10 - 04-Nov-26
Unknown* 0 13,944.00p OTC Trade
13:15:08 - 04-Nov-26
Buy* 82 13,944.00p Automatic Execution
13:15:08 - 04-Nov-26
Buy* 4 13,944.00p Automatic Execution
13:15:08 - 04-Nov-26
Unknown* 0 13,944.00p SI Trade
13:14:55 - 04-Nov-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
4th Nov 2026 (Wed) 13,768.00 13,954.00 13,582.00 13,760.00 629,298
3rd Nov 2026 (Tue) 13,964.00 13,984.00 13,760.00 13,760.00 2,536,172
2nd Nov 2026 (Mon) 13,704.00 13,932.00 13,678.00 13,860.00 2,990,997
30th Oct 2026 (Fri) 13,438.00 14,002.00 13,308.00 13,960.00 4,484,899
29th Oct 2026 (Thu) 12,808.00 13,166.00 12,790.00 13,052.00 1,420,886
28th Oct 2026 (Wed) 12,756.00 12,932.00 12,642.00 12,764.00 1,182,356
27th Oct 2026 (Tue) 12,848.00 12,912.00 12,724.00 12,822.00 2,232,121
26th Oct 2026 (Mon) 12,882.00 12,976.00 12,806.00 12,854.00 1,612,470
23rd Oct 2026 (Fri) 12,906.00 12,906.00 12,672.00 12,824.00 2,164,382
22nd Oct 2026 (Thu) 12,602.00 12,980.00 12,526.00 12,980.00 1,798,147
21st Oct 2026 (Wed) 12,602.00 12,688.00 12,536.00 12,614.00 1,768,475
20th Oct 2026 (Tue) 12,440.00 12,626.00 12,388.00 12,618.00 4,421,942
19th Oct 2026 (Mon) 12,440.00 12,468.00 12,298.00 12,400.00 2,087,819
16th Oct 2026 (Fri) 12,506.00 12,576.00 12,420.00 12,446.00 2,900,609
15th Oct 2026 (Thu) 12,396.00 12,806.00 12,334.00 12,698.00 5,441,321
14th Oct 2026 (Wed) 11,820.00 12,328.00 11,816.00 12,300.00 2,181,667
13th Oct 2026 (Tue) 12,170.00 12,310.00 11,884.00 11,896.00 2,152,002
12th Oct 2026 (Mon) 12,038.00 12,076.00 11,916.00 12,026.00 1,750,925
9th Oct 2026 (Fri) 12,024.00 12,112.00 11,982.00 11,998.00 4,463,681
8th Oct 2026 (Thu) 12,032.00 12,124.00 11,890.00 11,892.00 2,276,534
7th Oct 2026 (Wed) 11,912.00 12,180.00 11,894.00 12,180.00 1,721,191
6th Oct 2026 (Tue) 11,904.00 12,108.00 11,782.00 11,958.00 2,188,384
5th Oct 2026 (Mon) 11,900.00 11,970.00 11,716.00 11,764.00 1,618,185
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
2nd Nov 2026 3:05 pm RNS Admission of Further Securities to Trading
2nd Nov 2026 3:00 pm RNS Total Voting Rights
30th Oct 2026 7:00 am RNS 3rd Quarter Results
27th Oct 2026 7:30 am RNS Enhertu approved in EU for HER2-positive eBC
26th Oct 2026 2:16 pm RNS Holding(s) in Company
22nd Oct 2026 7:00 am RNS Ultomiris approved in US in IgAN
5th Oct 2026 12:00 pm RNS AstraZeneca completes equity investment in Summit
2nd Oct 2026 7:30 am RNS AZ & DS collaboration with Summit for Datroway
1st Oct 2026 3:05 pm RNS Admission of Further Securities to Trading
1st Oct 2026 3:00 pm RNS Total Voting Rights
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

LONDON BROKER RATINGS: Jefferies cuts Haleon; LBBW raises Shell target

4th Nov 2026 09:13

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

CORRECT: Jefferies raises Centrica; Davy cuts Vistry

3rd Nov 2026 10:21

(Corrects currency for Magnum to EUR.) Read More

LONDON BROKER RATINGS: Jefferies raises Centrica; Davy cuts Vistry

3rd Nov 2026 09:21

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

Hutchmed China hails Orpathys acceptance for review in Japan and EU

2nd Nov 2026 14:26

(Alliance News) - Hutchmed China Ltd on Monday said regulatory filings for Orpathys, alias savolitinib, in combination with Tagrisso have been accepted for review in Japan and the EU. Read More

LONDON BROKER RATINGS: Berenberg cuts Haleon, Barclays cuts Dr Martens

2nd Nov 2026 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,809.61
Change171.18

Login to your account

Forgot Password?

Not Registered